BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26443527)

  • 1. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation.
    Haverkamp L; van der Sluis PC; Ausems MG; van der Horst S; Siersema PD; Ruurda JP; Offerhaus GJ; van Hillegersberg R
    J Gastrointest Surg; 2015 Dec; 19(12):2120-5. PubMed ID: 26443527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
    Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
    J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
    [No Abstract]   [Full Text] [Related]  

  • 3. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.
    Strong VE; Gholami S; Shah MA; Tang LH; Janjigian YY; Schattner M; Selby LV; Yoon SS; Salo-Mullen E; Stadler ZK; Kelsen D; Brennan MF; Coit DG
    Ann Surg; 2017 Dec; 266(6):1006-1012. PubMed ID: 27759617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
    Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
    Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
    JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
    Guilford P; Humar B; Blair V
    Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.
    DiBrito SR; Blair AB; Prasath V; Habibi M; Harmon JW; Duncan MD
    J Surg Res; 2020 Mar; 247():438-444. PubMed ID: 31685251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?
    Chun YS; Lindor NM; Smyrk TC; Petersen BT; Burgart LJ; Guilford PJ; Donohue JH
    Cancer; 2001 Jul; 92(1):181-7. PubMed ID: 11443625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series.
    Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H
    World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?
    Zhang Q; Yang Z; Karamchandani DM
    Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic total gastrectomy for individuals with germline CDH1 mutation.
    Pandalai PK; Lauwers GY; Chung DC; Patel D; Yoon SS
    Surgery; 2011 Mar; 149(3):347-55. PubMed ID: 20719348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.
    Black MD; Kaneshiro R; Lai JI; Shimizu DM
    Hawaii J Med Public Health; 2014 Jul; 73(7):204-7. PubMed ID: 25089230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary gastric cancer.
    Carneiro F
    Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Diffuse Gastric Cancer Treated by Prophylactic Total Gastrectomy.
    Inaba Y; Goda K; Kondo M; Abe K; Kanamori A; Suzuki T; Tominaga K; Nakagawa M; Morita S; Kojima K; Ishida K; Irisawa A
    Intern Med; 2024 Jan; 63(2):235-239. PubMed ID: 37225495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study.
    Asif B; Sarvestani AL; Gamble LA; Samaranayake SG; Famiglietti AL; Fasaye GA; Quezado M; Miettinen M; Korman L; Koh C; Heller T; Davis JL
    Lancet Oncol; 2023 Apr; 24(4):383-391. PubMed ID: 36990610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.
    Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.